Tracks nemolizumab use in adolescents and adults with atopic dermatitis
Observes how nemolizumab works for moderate-to-severe atopic dermatitis in routine care.
Plain-language title generated from the registry record
Registry title: Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Key facts
- Where
- Auburn, Auburn Hills, Birmingham, Bluffton, Boca Raton, Bountiful, Brighton, Caledonia, Castle Rock, Cedar Park, Chicago, Columbia, Coral Gables, Corona, Cutler Bay, Dallas, Dayton, East Syracuse, Edinburg, Fairfield, Fountain Valley, Fremont, Glenn Dale, Grandville, Grapevine, Gresham, Hollywood, Indianapolis, Jupiter, Las Vegas, Lee's Summit, Los Angeles, Miami, Milford, Morgantown, Mount Kisco, New York, Newport Beach, North Miami Beach, Oakland Park, Philadelphia, Phoenix, Portsmouth, Rockville, Santa Monica, St. Petersburg, Sugar Land, Tampa, Thousand Oaks, Troy, Tucson, Vienna, Waco, and West Lafayette, United StatesSee the 59 sites
Where in United States
- Galderma Investigational Site - Site 7080Auburn, United StatesTaking people
- Auburn HillsAuburn Hills, United StatesNot yet recruiting
- BirminghamBirmingham, United StatesNo longer taking part
- BlufftonBluffton, United StatesNot yet recruiting
- Boca RatonBoca Raton, United StatesNot yet recruiting
- BountifulBountiful, United StatesNot yet recruiting
- BrightonBrighton, United StatesTaking people
- CaledoniaCaledonia, United StatesTaking people
- Castle RockCastle Rock, United StatesNot yet recruiting
- Cedar ParkCedar Park, United StatesTaking people
- ChicagoChicago, United StatesTaking people
- ColumbiaColumbia, United StatesTaking people
- Coral GablesCoral Gables, United StatesNot yet recruiting
- CoronaCorona, United StatesNot yet recruiting
- Cutler BayCutler Bay, United StatesTaking people
- DallasDallas, United StatesTaking people
- DaytonDayton, United StatesTaking people
- East SyracuseEast Syracuse, United StatesTaking people
- EdinburgEdinburg, United StatesNot yet recruiting
- FairfieldFairfield, United StatesTaking people
- Fountain ValleyFountain Valley, United StatesNot yet recruiting
- FremontFremont, United StatesTaking people
- Glenn DaleGlenn Dale, United StatesTaking people
- GrandvilleGrandville, United StatesNot yet recruiting
- GrapevineGrapevine, United StatesTaking people
- GreshamGresham, United StatesTaking people
- HollywoodHollywood, United StatesTaking people
- IndianapolisIndianapolis, United StatesTaking people
- JupiterJupiter, United StatesNot yet recruiting
- Las VegasLas Vegas, United StatesTaking people
- Lee's SummitLee's Summit, United StatesTaking people
- Los AngelesLos Angeles, United StatesNot yet recruiting
- MiamiMiami, United StatesTaking people
- MilfordMilford, United StatesTaking people
- MorgantownMorgantown, United StatesTaking people
- Mount KiscoMount Kisco, United StatesNot yet recruiting
- New YorkNew York, United StatesNot yet recruiting
- New YorkNew York, United StatesTaking people
- New YorkNew York, United StatesTaking people
- Newport BeachNewport Beach, United StatesTaking people
- North Miami BeachNorth Miami Beach, United StatesNot yet recruiting
- Oakland ParkOakland Park, United StatesNot yet recruiting
- PhiladelphiaPhiladelphia, United StatesNot yet recruiting
- PhiladelphiaPhiladelphia, United StatesNot yet recruiting
- PhoenixPhoenix, United StatesTaking people
- PhoenixPhoenix, United StatesTaking people
- PhoenixPhoenix, United StatesTaking people
- PortsmouthPortsmouth, United StatesTaking people
- RockvilleRockville, United StatesTaking people
- Santa MonicaSanta Monica, United StatesNot yet recruiting
- St. PetersburgSt. Petersburg, United StatesTaking people
- Sugar LandSugar Land, United StatesTaking people
- TampaTampa, United StatesTaking people
- Thousand OaksThousand Oaks, United StatesNot yet recruiting
- TroyTroy, United StatesNot yet recruiting
- TucsonTucson, United StatesNot yet recruiting
- ViennaVienna, United StatesNot yet recruiting
- WacoWaco, United StatesNot yet recruiting
- West LafayetteWest Lafayette, United StatesNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Galderma R&D
- Trial code
- NCT06988605
- Record updated
- 13 March 2026
- Original description
The main aim of the study is to assess real-world effectiveness of nemolizumab in Atopic Dermatitis (AD) as measured by physician assessment and patient reported outcome (PRO) in clinical practice at Month 6.Read full original descriptionShow less
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
The main aim of the study is to assess real-world effectiveness of nemolizumab in Atopic Dermatitis (AD) as measured by physician assessment and patient reported outcome (PRO) in clinical practice at Month 6.
Inclusion: Participants who, according to the treating physician's decision and in line with the local package label, start treatment with nemolizumab (Nemluvio®); Adolescent and adult participants aged >=12 years with moderate-to-severe AD; Participants who signed the written informed consent form (ICF) or had it signed by their legal representative.
Exclusion: Participants who received treatment with a drug under clinical development/investigation within 3 months prior to baseline; Participants who received nemolizumab previously; Have contraindication(s) for the use of nemolizumab (Nemluvio®) according to the local package label; Participants who are mentally, physically, or linguistically unable to understand the content of the ICF and/or to complete the study questionnaires.